| p53 and breast cancer, an update M Lacroix, RA Toillon, G Leclercq Endocrine-related cancer 13 (2), 293-325, 2006 | 589 | 2006 |
| Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways S Descamps, RA Toillon, E Adriaenssens, V Pawlowski, SM Cool, ... Journal of Biological Chemistry 276 (21), 17864-17870, 2001 | 289 | 2001 |
| TrkA overexpression enhances growth and metastasis of breast cancer cells C Lagadec, S Meignan, E Adriaenssens, B Foveau, E Vanhecke, ... Oncogene 28 (18), 1960-1970, 2009 | 242 | 2009 |
| NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatment N Magné, RA Toillon, V Bottero, C Didelot, P Van Houtte, JP Gérard, ... Cancer letters 231 (2), 158-168, 2006 | 241 | 2006 |
| Radiation-enhanced cell migration/invasion process: a review C Moncharmont, A Levy, JB Guy, AT Falk, M Guilbert, JC Trone, ... Critical reviews in oncology/hematology 92 (2), 133-142, 2014 | 196 | 2014 |
| Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether. a-gogo K+ channel. H Ouadid-Ahidouch, X Le Bourhis, M Roudbaraki, RA Toillon, P Delcourt, ... Receptors & channels 7 (5), 345-356, 2001 | 196 | 2001 |
| Stable ‘portrait’of breast tumors during progression: data from biology, pathology and genetics M Lacroix, RA Toillon, G Leclercq Endocrine-related cancer 11 (3), 497-522, 2004 | 187 | 2004 |
| (−)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts D Vergote, C Cren-Olivé, V Chopin, RA Toillon, C Rolando, ... Breast cancer research and treatment 76, 195-201, 2002 | 150 | 2002 |
| Sodium butyrate induces P53‐independent, Fas‐mediated apoptosis in MCF‐7 human breast cancer cells V Chopin, RA Toillon, N Jouy, XL Bourhis British journal of pharmacology 135 (1), 79-86, 2002 | 127 | 2002 |
| P21WAF1/CIP1 is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells V Chopin, RA Toillon, N Jouy, X Le Bourhis Oncogene 23 (1), 21-29, 2004 | 123 | 2004 |
| Ferroquine, the next generation antimalarial drug, has antitumor activity A Kondratskyi, K Kondratska, F Vanden Abeele, D Gordienko, C Dubois, ... Scientific reports 7 (1), 1-15, 2017 | 92 | 2017 |
| Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein Y Demont, C Corbet, A Page, Y Ataman-Önal, G Choquet-Kastylevsky, ... Journal of Biological Chemistry 287 (3), 1923-1931, 2012 | 92 | 2012 |
| A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines A Vessières, C Corbet, JM Heldt, N Lories, N Jouy, I Laïos, G Leclercq, ... Journal of inorganic biochemistry 104 (5), 503-511, 2010 | 85 | 2010 |
| Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells I Laïos, F Journé, D Nonclercq, DS Vidal, RA Toillon, G Laurent, ... The Journal of steroid biochemistry and molecular biology 94 (4), 347-359, 2005 | 81 | 2005 |
| Neurotrophin signaling in cancer stem cells V Chopin, C Lagadec, RA Toillon, X Le Bourhis Cellular and molecular life sciences 73 (9), 1859-1870, 2016 | 65 | 2016 |
| Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens I Laı̈os, F Journe, G Laurent, D Nonclercq, RA Toillon, HS Seo, ... The Journal of steroid biochemistry and molecular biology 87 (2-3), 207-221, 2003 | 62 | 2003 |
| Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells C Lagadec, E Adriaenssens, RA Toillon, V Chopin, R Romon, ... Oncogene 27 (10), 1472-1477, 2008 | 61 | 2008 |
| Proteomics of breast cancer: the quest for markers and therapeutic targets H Hondermarck, C Tastet, I El Yazidi-Belkoura, RA Toillon, X Le Bourhis Journal of proteome research 7 (4), 1403-1411, 2008 | 60 | 2008 |
| Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? C Chargari, RA Toillon, D MacDermed, P Castadot, N Magné The lancet oncology 10 (1), 53-60, 2009 | 59 | 2009 |
| Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines A Steenackers, S Olivier-Van Stichelen, SF Baldini, V Dehennaut, ... Frontiers in Endocrinology 7, 46, 2016 | 54 | 2016 |
